BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20629842)

  • 21. Pseudocarcinomatous hyperplasia with follicular differentiation overlying basal cell carcinoma.
    Tuttle MS; Rosenberg AS; Winfield HL; Somach SC
    Am J Dermatopathol; 2009 Aug; 31(6):557-60. PubMed ID: 19590419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway.
    Chu CY; Cha ST; Lin WC; Lu PH; Tan CT; Chang CC; Lin BR; Jee SH; Kuo ML
    Carcinogenesis; 2009 Feb; 30(2):205-13. PubMed ID: 18849299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal cell carcinoma with osteosarcomatous component.
    Tse JY; Pawlak AC; Boussahmain C; Routhier CA; Dias-Santagata D; Kalomiris D; Hoang MP
    Am J Dermatopathol; 2013 Apr; 35(2):261-5. PubMed ID: 23221485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Basal-cell carcinoma of the skin].
    Chuprov IN
    Arkh Patol; 2007; 69(6):52-5. PubMed ID: 18290385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic basal cell carcinoma in children.
    Alcalay J; Ben-Amitai D; Alkalay R
    J Drugs Dermatol; 2008 May; 7(5):479-81. PubMed ID: 18505143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal Cell Carcinoma With Matrical Differentiation: Clinicopathologic, Immunohistochemical, and Molecular Biological Study of 22 Cases.
    Kyrpychova L; Carr RA; Martinek P; Vanecek T; Perret R; Chottová-Dvořáková M; Zamecnik M; Hadravsky L; Michal M; Kazakov DV
    Am J Surg Pathol; 2017 Jun; 41(6):738-749. PubMed ID: 28368926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rippled-pattern basal cell carcinoma.
    Misago N; Tsuruta N; Narisawa Y
    J Dermatol; 2012 Jul; 39(7):632-5. PubMed ID: 22211777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Specific characteristics of skin basal cell carcinoma invasion].
    Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
    Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basaloid tumors in nevus sebaceus revisited: the follicular stem cell marker PHLDA1 (TDAG51) indicates that most are basal cell carcinomas and not trichoblastomas.
    Sellheyer K; Cribier B; Nelson P; Kutzner H; Rütten A
    J Cutan Pathol; 2013 May; 40(5):455-62. PubMed ID: 23489134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Giant basal cell carcinoma of the back: a case report and review of the literature.
    Bogdanić B; Smud S; Bagatin D; Nola M; Mijatović D; Majerović M
    Coll Antropol; 2009 Mar; 33(1):315-8. PubMed ID: 19408644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sarcomatoid basal cell carcinoma.
    Ríos-Martín JJ; González-Cámpora R; Moreno-Ramírez D; Camacho-Martínez F
    Am J Dermatopathol; 2005 Dec; 27(6):546; author reply 546. PubMed ID: 16314711
    [No Abstract]   [Full Text] [Related]  

  • 32. Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.
    Choi CW; Park HS; Kim YK; Lee SH; Cho KH
    J Dermatol; 2008 Aug; 35(8):499-502. PubMed ID: 18789069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High numbers of human skin cancers express MMP2 and several integrin genes.
    Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR
    J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM; Cabral E; Dadras SS; Cassarino DS
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basal cell carcinoma with matrical differentiation: a case study with analysis of beta-catenin.
    Haskell HD; Haynes HA; McKee PH; Redston M; Granter SR; Lazar AJ
    J Cutan Pathol; 2005 Mar; 32(3):245-50. PubMed ID: 15701088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collision tumor of malignant skin cancers: a case of melanoma in basal cell carcinoma.
    Papa G; Grandi G; Pascone M
    Pathol Res Pract; 2006; 202(9):691-4. PubMed ID: 16876964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
    Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
    J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An immunohistochemical study of laminin in basal cell carcinoma.
    Mostafa WZ; Mahfouz SM; Bosseila M; Sobhi RM; El-Nabarawy E
    J Cutan Pathol; 2010 Jan; 37(1):68-74. PubMed ID: 19615022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
    Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
    Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.